News Focus
News Focus
Followers 57
Posts 3155
Boards Moderated 0
Alias Born 02/01/2017

Re: Horseb4CarT post# 513052

Sunday, 09/11/2022 11:43:15 PM

Sunday, September 11, 2022 11:43:15 PM

Post# of 824216
Horse, the survival numbers I posted do not support your hypothesis. Elicitation of immunity by the mesenchymal signature of the recurrent tumor may explain much of the success of the rGBM patients. We have to go with the numbers surviving at each time interval and then analyze the reasons for the results.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News